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Among 25 patients diagnosed with Angel-
man syndrome, we detected 21 with deletion
and 4 with paternal uniparental disomy
(UPD), 2 isodisomies originating by postzy-
gotic error, and 1 MII nondisjunction event.
The diagnosis was obtained by molecular
techniques, including methylation pattern
analysis of exon 1 of SNRPN and microsat-
ellite analysis of loci within and outside the
15q11-q13 region. Most manifestations pres-
ent in deletion patients are those previously
reported. Comparing the clinical data from
our and published UPD patients with those
with deletions we observed the following:
the age of diagnosis is higher in UPD group
(average 7 3⁄12 years), microcephaly is more
frequent among deletion patients, UPD chil-
dren start walking earlier (average age 2 9⁄12
years), whereas in deletion patients the av-
erage is 4 1⁄2 years, epilepsy started later in
UPD patients (average 5 10⁄12 years) than in
deletion patients (average 1 11⁄12 years),
weight above the 75th centile is reported
mainly in UPD patients, complete absence
of speech is more common in the deleted
(88.9%) than in the UPD patients because
half of the children are able to say few
words. Thus, besides the abnormalities al-
ready described, the UPD patients have
somewhat better verbal development, a
weight above the 75th centile, and OFC in
the upper normal range. Am. J. Med. Genet.
92:322–327, 2000. © 2000 Wiley-Liss, Inc.





Angelman syndrome (AS) [Angelman, 1965] com-
prises hypotonia (90%), severe mental retardation
(100%), absent speech (98%), seizures (80%), ataxia
(100%), outbursts of laughter, micro and/or brachy-
cephaly (90%), macrostomia (75%), and prognathism
(95%). The gait is described as wide-based with arms
held flexed and upheld at the elbows [Clayton-Smith
and Pembrey, 1992; Fryburg et al., 1991; Robb et al.,
1989].
The Prader-Willi (PWS) (hypotonia, obesity, and hy-
perphagia) and Angelman syndromes are clear ex-
amples of genomic imprinting in humans because the
clinical manifestation of these syndromes depends on
the sex of the parent-of-origin of mutations within the
15q11-q13 region. The genetic basis of AS is complex,
and at present, it is unknown whether the syndrome is
caused by the loss of function of a single gene or wheth-
er different genes are involved [Bürger et al., 1997].
About two thirds of the AS cases are due to maternal
deletion within 15q11-q13 [Magenis et al., 1987; Knoll
et al., 1989]; paternal uniparental disomy of chromo-
some 15 (UPD15) is detected in 2–3% [Nicholls, 1993];
approximately 2% of individuals show imprinting con-
trol center mutations identified by abnormal methyl-
ation pattern [Buiting et al., 1995, 1998; Glenn et al.,
1997; Saitoh et al., 1996; Sutcliffe et al., 1994]; about
8% show mutations in the UBE3A gene [Kishino et al.,
1997; Malzac et al., 1998; Matsuura et al., 1997], and
there is a class of AS patients with undetected genetic
mechanism. Recurrence risk in deletion and UPD cases
is less than 1% and for familial imprinting mutation
and UBE3A mutation may be 50% [Burger et al., 1997;
Saitoh et al., 1997].
In general, AS is not suspected during the first year
of life, but it is better recognized around 3–4 years of
age. Some characteristics, such as seizures, outbursts
of laughter, macrostomia, prognathism, and wide-
based gait, become more evident after age 2 years;
asymmetrical face and scoliosis can occur only at pu-
berty [Buntinx et al., 1995]. An electroencephalogram
(EEG) study can be useful for diagnosis if some of the
AS characteristics are present; nevertheless, some of
those manifestations are age-dependent and can disap-
pear in older children [Clayton-Smith, 1992].
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Several authors suggested that AS patients with uni-
parental disomy (UPD) have a milder phenotype than
patients with deletions [Bottani et al., 1994; Freeman
et al., 1993; Gillessen-Kaesbach et al., 1995; Smith et
al., 1997]. They pointed out that children with UPD
have better physical growth, fewer or no seizures, less
ataxia, and higher cognitive skills. Hypopigmentation
is the only finding more common in deleted AS pa-
tients, because the gene responsible for pigmentation
(P), located in the distal position of the 15q11-q13 re-
gion, is not imprinted.
In this study we describe the clinical and behavioral
manifestations of four cases of paternal UPD15 in Bra-
zilian AS children. We compared these cases and pub-
lished UPD cases [Bottani et al., 1994; Freeman et al.,
1993; Gillessen-Kaesbach et al., 1995; Malcolm et al.,
1991; Nicholls et al., 1992; Prasad and Wagstaff, 1997;
Smeets et al., 1992; Smith et al., 1997, 1998] to our
deleted patients (n 4 21) and show that better speech
development, weight above the 75th centile and outer
frontal circumference (OFC) in the upper normal range
should be added to clinical variability present in pa-
tients with Angelman syndrome.
MATERIALS AND METHODS
Patients
Twenty-five patients (9 boys and 16 girls with ages
ranging from 1 5/12 to 11 years) with Angelman syn-
drome were referred from neurologists of the Hospital
das Clı́nicas, School of Medicine, University of São
Paulo, Brazil.
Cytogenetic Studies
Chromosome of patients and parents were studied
with the GTG-banding technique.
Fluorescence in situ hybridization (FISH) was per-
formed by using a probe specific for the 15q11-q13 re-
gion. The probe GABRB3 was obtained from Oncor,
Inc. (Gaithersburg, MD), and the hybridization and im-
munochemical detection were performed according to
the manufacturer’s instructions. The probe also con-
tains control chromosome 15 marker cosmids that de-
tect specific sequences in 15q22; 20 cells were exam-
ined on each patient.
DNA Analysis
Methylation analysis. DNA was extracted from
peripheral blood leukocytes by standard procedures.
The methylation status of the PWS/AS region was as-
sessed by Southern blotting [Southern, 1975]. Genomic
DNA was digested with XbaI + NotI, separated by size
on a 1.0% agarose gel, transferred to a nylon mem-
brane, and hybridized by using the probe that corre-
sponds to a 0.6-kb EcoRI-NotI fragment that contains
exon 1 of SNRPN [Glenn et al., 1996].
Dinucleotide repeat (CA)n polymorphisms
within and outside the PWS/AS critical region.
Microsatellite analyses were performed with three
markers within the critical region 15q11-q13, 4-3RCA
(D15S11), LS6-1CA (D15S113), and GABRB3CA
(GABRB3), and two loci outside the PWS/AS region
(D15S131 and D15S984) were studied to distinguish
between deletion and UPD (data not shown). Deletion
is disclosed if no maternal and only one of the two pa-











Age at diagnosis (yr) 9 10 1/2 7 3 1/2 4 3/12
(range) (1 5/12–11)
Maternal age (yr) 30 40 23 29 28 1/2
(range) (18–39)
Paternal age (yr) 33 47 25 37 32 9/12
(range) (26–52)
Birth weight (centile) (g) 3780 2400 3600 3150 2992.6 (p25)
Birth height (centile) (cm) 50 46 na 48 49.1 (p25)
Length (centile)
<25 35.3% (6/18)
25–75 + 47.0% (8/18)
>75 + + + 17.6% (3/17)
Weight (centile)
<25 33.3% (6/18)
25–75 + 44.4% (8/18)
>75 + + + 22.2% (4/18)
Developmental delay + + + + 100% (19/19)
Microcephaly − − − − 47.4% (9/19)
Absence of speech + + 88.9% (16/18)
Few words + + 11.1% (2/18)
Independent gait (yr) 2 8/12 na 3 − 3 1/2
(range) (2 3/12–8)
Hyperactivity + na + − 93.3% (14/15)
Seizures − + − − 94.4% (17/18)
Onset of seizures (yr) 8 1 9/12
(range) (6/12–4)
*+, presence; −, absence; na, data not available; iso, isodisomy.
aFridman et al., 1998.
bFridman et al., 2000.
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ternal alleles are present within the PWS/AS region
and biparental inheritance is demonstrated outside
this region. The presence of one paternal allele or two
different paternal alleles within and outside PWS/AS
region and no maternal alleles disclose isodisomy or
heterodisomy, respectively. For UPD patients we also
analyzed the loci D15S541 and D15S542, localized
close to the centromere, which allow us to disclose the
meiotic origin of the nondisjunction [Robinson et al.,
1998] and additional loci outside the PWS/AS region
(CYP19, D17S117, and D15S115). A postzygotic error
was considered when all markers along the entire chro-
mosome 15 showed an isodisomic state. The multiplex
polymerase chain reaction (PCR) and polyacrylamide
gel electrophoresis of 32P end-labeled amplification
products followed the method described by Mutiran-
gura et al. [1993].
Statistical Analysis
Statistical analysis was performed with Fisher’s test,
Student’s t-test, and Mann-Whitney’s test by using the
level of confidence of a 4 0.05 as a statistically signifi-
cant difference.
RESULTS
In our 25 AS patients, deletion was detected in 21 (14
girls and 7 boys) and UPD in 4 individuals (2 girls and
2 boys). Clinical characteristics of our UPD patients
are presented in Table I and some patients are seen in
Fig. 1. AS patients with (a) UPD and (b–e) deletion. a: 7 years; b: 5 4/12 years; c: 2 years; d: 3 10/12 years; e: 2 10/12 years.
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Figure 1. A comparison between our deleted children
and all published UPD patients is shown in Table II.
In the molecular investigation, all the patients
showed only the 0.9-kb nonmethylated paternal band
when SNRPN methylation pattern was tested, con-
firming the AS diagnosis (data not shown). Analysis of
microsatellites within and outside the PWS/AS region
was performed in all patients. The markers within
PWS/AS region disclosed only one of the paternal
bands, for at least 1 locus, in all cases except in patient
3 who had two paternal bands, indicating heterodisomy
for this region; the biparental inheritance of the mark-
ers outside the PWS/AS region demonstrated deletion
in 21 cases. In four cases, with normal FISH results,
UPD was confirmed when the loci outside the PWS/AS
region were tested (Table III).
The study of loci D15S541 and D15S542 performed
in the four UPD patients showed three isodisomies (pa-
tients 1, 2, and 4), and one noninformative case (pa-
tient 3). Patient 1 has the karyotype 45,XY, t(15;15)
and was described previously [Fridman et al., 1998].
Besides being homozygous for the D15S542, D15S11,
D15S113, and GABRB3 loci, patient 2 showed one
crossover between the PWS/AS region (homozygous)
and locus CYP19 (heterozygous) (Table III). So, we con-
clude that this patient results from a meiosis II non-
TABLE III. Microsatellites Analysis of the UPD AS Patients*
D15S541 D15S542 D15S11 D15S113 GABRB3 CYP19 D15S117 D15S131 D15S984 D15S115

















Mother 3,4 3,4 2,4 1,1 1,2 1,4 2,2 3,3 2,3 1,2
1 1,1 1,1 1,1 1,1 3,3 2,2 3,3 3,3 2,2 4,4
Father 1,2 1,2 1,3 1,2 3,3 2,3 1,3 1,3 1,2 3,4
Mother 2,3 2,3 1,2 2,3 3,3 1,1 2,3 1,3 2,3 2,2
2 1,1 4,4 1,1 2,2 1,1 1,2 1,4 2,4 1,1 1,3
Father 1.1 1,4 1,3 1,2 1,2 1,2 1,4 2,4 1,1 1,3
Mother 1,1 1,1 — 1,4 2,3 1,3 1,2 1,2 1,3 1,2
3 2,2 2,2 — 2,3 1,2 2,2 1,1 1,1 2,2 2,2
Father na na — na na na na na na na
Mother 1,3 1,3 — 2,2 1,1 2,4 1,2 1,2 1,3 1,3
4 2,2 2,2 — 1,1 2,2 1,1 4,4 2,2 3,3 4,4
Father 2,4 2,3 — 1,3 2,3 1,3 3,4 2,3 2,3 2,4
*The markers are ordered from centromere to telomere, and the distances are based on Dib et al. [1996] and Robinson and Knoll [1997]. na, not available;
italic, critical PWS/AS region; bold, the informative data.
TABLE II. Comparison of Clinical Findings Between Our Deleted Patients and





Age at diagnosis (yr) 7 3/12 4 3/12 (1) 0.0251
(range) (2 9/12–10 6/12) (1 5/12–11)
Maternal age (yr) 28 8/12 27 3/12 (1) 0.7943
(range) (14–43) (18–39)
Paternal age (yr) 32 7/12 31 11/12 (1) 0.5443
(range) (22–47) (26–52)
Birth weight (centile) 3232 g 2872 g (2) 0.3337
Birth height (centile) 48 cm 48.8 cm (2) 0.3712
Length (centile)
<25 16.7% (3/18) 31.6% (6/19) (3) 0.4470
25–75 38.9% (7/18) 52.6% (10/19) (3) 0.5148
>75 44.5% (8/18) 15.8% (3/19) (3) 0.0789
Weight (centile)
<25 11.8% (2/17) 30.0% (6/20) (3) 0.2455
25–75 17.6% (3/17) 50.0% (10/20) (3) 0.0823
>75 70.6% (12/17) 20.0% (4/20) (3) 0.0030
Developmental delay 100% (19/19) 100% (21/21) (3) 1.0000
Microcephaly 15.8% (3/19) 57.9% (11/19) (3) 0.0170
Absence of speech 47.4% (9/19) 88.9% (16/18) (3) 0.0128
Independent gait (yr) 2 9/12 4 1/2 (1) 0.0097
(range) (1 10/12–6) (2 3/12–8)
Hyperactivity 90.9% (10/11) 93.7% (15/16) (3) 1.0000
Seizures 42.1% (8/19) 81.7% (18/21) (3) 0.0072
Onset of seizures (yr) 5 10/12 1 11/12 (1) 0.0010
(range) (1 1/2–12) (6/12–4)
*The bold data indicated those with statistical significance.
aOur 4 UPD cases plus the UPD patients already described [Bottani et al., 1994; Freeman et
al., 1993; Gillessen–Kaesbach et al., 1995; Malcolm et al., 1991; Nicholls et al., 1992; Prasad
and Wagstaff, 1997; Smeets et al., 1992; Smith et al., 1997, 1998].
bStatistical test using significance level of a 4 0.005. (1) Mann-Whitney’s test; (2) Student’s
t-test; (3) Fisher’s test.
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disjunction because we documented an isodisomy with
1 crossover [Fridman et al., 2000].
Patient 3 had two different nonmaternal alleles in
the PWS/AS critical region and only one allele (homo-
zygous) at the centromeric loci D15S541 and D15S542;
because the paternal DNA sample was not available,
we cannot conclude the type of UPD in this case. The
other two cases showed reduction (homozygous) for all
tested markers, suggesting a postzygotic error. The
molecular results of UPD patients are summarized in
Table III.
All parents had normal karyotypes.
By comparing the two groups of AS patients, we ob-
served statistically significant clinical differences be-
sides those already described: delayed age-of-diagnosis
and weight above the 75th centile in the UPD cases,
prevalence of microcephaly in deleted patients, com-
plete absence of speech more common in the deleted
group and capacity to speak a few words in the UPD
group, early walking in the UPD cases, and earlier on-
set of seizures in the deleted group.
DISCUSSION
This work is part of a research project on Brazilian
AS children, and the diagnosis of AS was confirmed in
all patients through the SNRPN methylation analysis.
This test has been used as a diagnostic tool for AS and
PWS because the methylation pattern is parent-
specific in this region [Gillessen-Kaesbach et al., 1995;
Glenn et al., 1996; Kubota et al., 1996; Saitoh et al.,
1997] and detects 80% of the AS and 95% of the PWS
patients.
Some findings in our patients are those commonly
observed in AS children: brachycephaly (88%), macro-
stomia (100%) and wide-spaced teeth (100%). All of our
children showed happy disposition with a constant
smile or outbursts of laughter that sometimes looks
inappropriate, and an easily excitable personality with
hand flapping, ataxic gait with arms flexed and upheld
at the elbows, sleep disturbance, love of water, and
mirror reflection [Clayton-Smith, 1993; Clayton-Smith
and Pembrey, 1992; Knoll et al., 1989; Williams et al.,
1995; Zori et al., 1992]. AS children usually have a
normal OFC at birth, but microcephaly can be detected
around 1 year [Fryburg et al., 1991]. In our deleted
patients microcephaly (OFC < 2nd centile) was present
in 11 of 19 (57.9%) and in only 15.8% (3 of 19) of the
UPD patients already described (Table II), but none of
our four cases presented this trait (Table I).
Smith et al. [1996] described the clinical signs in 27
AS patients with deletion and concluded that the phe-
notypic variability observed in deletion patients can be
observed in UPD patients and that there are no differ-
ences between these two groups, except for the lower
incidence of seizures and gait improvement in UPD
cases. By comparing the clinical data from 15 pub-
lished UPD patients [Bottani et al., 1994; Freeman et
al., 1993; Gillessen-Kaesbach et al., 1995; Malcolm et
al., 1991; Nicholls et al., 1992; Prasad and Wagstaff,
1997; Smeets et al., 1992; Smith et al., 1997, 1998],
including our four, with data from our 21 deletion pa-
tients, some significant differences were observed
(Table II): the age of diagnosis is higher in UPD chil-
dren (average 7 3⁄12 years), mainly because the pheno-
typic and behavioral traits are more subtle; microceph-
aly is more frequent among deletion patients; UPD
children start walking earlier (average age 2 9⁄12 years),
whereas in our deleted patients it is on the average 4 1⁄2
years; epilepsy started later in UPD patients (average
5 10⁄12 years) than in our deleted patients (average 1
11⁄12 years); weight above the 75th centile is reported
mainly in UPD patients; although all patients showed
speech impairment, complete absence of speech is more
common in the deleted (88.9%) than in UPD patients
where half of the children are able to say a few words
(Table II).
The origin of a UPD individual depends on nondis-
junction events that are associated with increased pa-
rental age [Robinson et al., 1993, 1996]. However,
when parental ages of UPD and deletions patients
were analyzed all together, no differences could be de-
tected (Table II).
Despite clinical variability, UPD patients seem to
have a milder phenotype with later onset of epilepsy
and better motor development [Bottani et al., 1994;
Gillessen-Kaesbach et al., 1995; Smith et al., 1998]. We
suggest that the capacity to say some words and body
weight and OFC in the upper normal range should be
included in the clinical spectrum of AS. These findings
corroborate the hypothesis that the severe phenotype
of deleted patients is caused by haploinsufficiency of
other genes in the deleted region [Ohta et al., 1999].
Because AS UPD patients could have a less typical
phenotype, it is possible that they are underdiagnosed
and the prevalence rate of 1:20,000 is underestimeted
[Kyllerman, 1995].
Recently it was suggested that microcephaly seems
to be less frequent in AS subgroups without deletion
[Saitoh et al., 1999] and that ataxia and seizures are
absent in the UBE3A mutation patients [Moncla et al.,
1999]. This information is important to decide which
patient with normal methylation and microsatellites
studies should be submitted to UBE3A mutation analy-
sis.
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